Philip R. Krause, M.D., Former FDA Deputy Chief for Vaccines, Joins Mesoblast Board
NEW YORK, March 23, 2022 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…
News
Rani Therapeutics to Release Fourth Quarter and Full Year 2021 Financial Results on Tuesday, March 29, 2022
SAN JOSE, Calif., March 23, 2022 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”…
Introducing SpaceMeta: the First Space Gaming Metaverse
London, United Kingdom–(Newsfile Corp. – March 23, 2022) – The SpaceMeta token project is the…
VCREDIT Announces a Final Dividend of HK15 cents
HONG KONG, Mar 24, 2022 – (ACN Newswire) – VCREDIT Holdings Limited (“VCREDIT” or the…
Yowie Group Launches “Fill Baskets and Hearts with Yowie” Easter Campaign
NEW YORK / PERTH, Mar 24, 2022 – (ACN Newswire) – Yowie Group, the confectionary…
CIS Global by nVent Celebrates Grand Opening of New PDU Manufacturing Facility in Tucson, Ariz.
The New Facility is the Company’s First in North America TUCSON, Ariz.–(BUSINESS WIRE)–nVent Electric plc…
CORRECTING and REPLACING Halodi Robotics Inks Contract with ADT Commercial for Delivery of 140 Humanoid Robots
Rollout of 140 service robots represents industry’s single biggest contract for humanoid robots to provide…
Genworth Financial Announces Election of Elaine Sarsynski to Board of Directors
RICHMOND, Va.–(BUSINESS WIRE)–$GNW #genworth–Genworth Financial, Inc. (NYSE: GNW) today announced the election of a new…
ProQR to Participate in the Cantor Virtual Rare Orphan Disease Summit
LEIDEN, Netherlands & CAMBRIDGE, Mass., March 23, 2022 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:…
RVL Pharmaceuticals plc to Discuss Fourth Quarter and Full Year 2021 Financial Results and Provide First Quarter 2022 Update on Medical Aesthetic Launch
— Conference call to be held March 30, 2022, at 4:30 p.m. ET — BRIDGEWATER,…
Century Therapeutics to Present at the H.C. Wainwright Gene Therapy and Gene Editing Conference
PHILADELPHIA, March 23, 2022 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company…
Novartis Pluvictoâ„¢ approved by FDA as first targeted radioligand therapy for treatment of progressive, PSMA positive metastatic castration-resistant prostate cancer
Ad hoc announcement pursuant to Art. 53 LR FDA also approved complementary diagnostic imaging agent,…
Centessa Pharmaceuticals to Present at the Guggenheim Genomic Medicines & Rare Disease Day
BOSTON and LONDON, March 23, 2022 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA) announced…
CytomX Therapeutics Announces Retirement of Frederick W. Gluck from Board of Directors
SOUTH SAN FRANCISCO, Calif., March 23, 2022 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX),…
Cocrystal Pharma Reports 2021 Financial Results and Provides Updates on Development Programs and Milestones
Commenced enrollment in Phase 1 trial with orally administered, broad-spectrum antiviral agent CC-42344 for the…
Homology Medicines Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights
– Formed New AAV Manufacturing and Innovation Business with Oxford Biomedica to Leverage Homology’s Process…
Mustang Bio Reports Full-Year 2021 Financial Results and Recent Corporate Highlights
WORCESTER, Mass., March 23, 2022 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a…
Lumos Pharma to Participate in the Cantor Rare Disease Symposium
AUSTIN, Texas, March 23, 2022 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company…
Reneo Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
IRVINE, Calif., March 23, 2022 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical…
Imago BioSciences Appoints Michael Arenberg to Chief Operating and Business Officer
Mr. Arenberg brings over 25 years of experience in the biopharmaceutical industry SOUTH SAN FRANCISCO,…